ni.zielinski
Submits third-party assay reports on material purchased directly. Based in Kumasi.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
8
n=8
Annotations
0
n=0
Median purity submitted
98.59%
n=8
Suppliers covered
8
n=8
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042776 | BPC-157 | GGPeps | GGPE-2602-N9882 | Janoshik | 2026-Q2 | 98.68 | 5.73 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043556 | MK-677 (Ibutamoren mesylate) | BCH | BCH-2601-G7069 | Janoshik | 2026-Q1 | 98.30 | 3.61 | 88.8 | Supplier-supplied | 2 | FAIL |
| AX-2026-042442 | MGF | SWB | SWB-2601-E6319 | Medutest | 2026-Q1 | 97.98 | 5.03 | 95.7 | Laboratory-retained | 0 | PASS |
| AX-2025-019998 | CJC-1295 with DAC | ERP | ERP-2507-A6393 | PeptideMeter | 2025-Q4 | 99.52 | 3.25 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019641 | Semaglutide | Homopeptide | HOMO-2508-K2535 | Janoshik | 2025-Q4 | 99.24 | 3.54 | 96.2 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020600 | Semaglutide | SSA | SSA-2508-Y6894 | Medutest | 2025-Q3 | 98.51 | 5.01 | 105.9 | Supplier-supplied | 3 | MARGINAL |
| AX-2025-019299 | ARA-290 | TFC | TFC-2501-K7199 | VendorInvestigate | 2025-Q2 | 99.33 | 5.31 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2024-005357 | Kisspeptin-10 | CPC | CPC-2411-W1680 | Janoshik | 2024-Q4 | 98.23 | 3.36 | 102.8 | Laboratory-retained | 2 | FAIL |